These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21447928)

  • 1. [Morphological analysis of bone dynamics and metabolic bone disease. Renal Osteodystrophy and New KDIGO CKD-MBD classification].
    Tsukamoto Y
    Clin Calcium; 2011 Apr; 21(4):593-7. PubMed ID: 21447928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic kidney disease (CKD) and bone. From renal osteodystrophy to CKD-MBD: new disease entity].
    Tsukamoto Y
    Clin Calcium; 2009 Apr; 19(4):479-84. PubMed ID: 19329825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Morphological analysis of bone dynamics and metabolic bone disease. Bone Histomorphometry in CKD-MBD (chronic kidney disease mineral bone disorder)].
    Yamamoto N
    Clin Calcium; 2011 Apr; 21(4):589-92. PubMed ID: 21447927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone biopsy and histomorphometrical analysis].
    Tsukamoto Y
    Clin Calcium; 2012 Jul; 22(7):1019-24. PubMed ID: 22750934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease-mineral-bone disorder: a new paradigm.
    Moe SM; Drüeke T; Lameire N; Eknoyan G
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):3-12. PubMed ID: 17200038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone metabolism in CKD-MBD].
    Kazama JJ
    Clin Calcium; 2010 Jul; 20(7):1038-44. PubMed ID: 20585182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving global outcomes in mineral and bone disorders.
    Moe SM; Drüeke T
    Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S127-30. PubMed ID: 18988697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone metabolic marker in hemodialysis patients update].
    Okuno S
    Clin Calcium; 2012 Jul; 22(7):1009-17. PubMed ID: 22750933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers of bone turnover. New aspect. Dialysis and bone metabolic marker].
    Okuno S; Inaba M
    Clin Calcium; 2009 Aug; 19(8):1084-91. PubMed ID: 19638691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone histology in chronic kidney disease-related mineral and bone disorder.
    Kazama JJ
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():23-5. PubMed ID: 21595848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients.
    Keronen S; Martola L; Finne P; Burton IS; Kauppila L; Kröger H; Larsson TE; Honkanen E
    Clin Nephrol; 2016 Mar; 85(3):127-34. PubMed ID: 26833298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disorders of bone and mineral metabolism in CKD: CKD-MBD as a new entity].
    Tsukamoto Y
    Clin Calcium; 2007 May; 17(5):660-4. PubMed ID: 17470993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is bone biopsy necessary for the diagnosis of metabolic bone diseases? Necessity of bone biopsy].
    Ito A; Yajima A
    Clin Calcium; 2011 Sep; 21(9):1388-92. PubMed ID: 21881202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
    Sabbagh Y; Graciolli FG; O'Brien S; Tang W; dos Reis LM; Ryan S; Phillips L; Boulanger J; Song W; Bracken C; Liu S; Ledbetter S; Dechow P; Canziani ME; Carvalho AB; Jorgetti V; Moyses RM; Schiavi SC
    J Bone Miner Res; 2012 Aug; 27(8):1757-72. PubMed ID: 22492547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mineral and bone disturbances associated with chronic kidney disease].
    Suchowierska E; Myśliwiec M
    Pol Merkur Lekarski; 2010 Feb; 28(164):138-43. PubMed ID: 20369744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO.
    Carbonara CEM; Reis LMD; Quadros KRDS; Roza NAV; Sano R; Carvalho AB; Jorgetti V; Oliveira RB
    J Bras Nefrol; 2020 Jan; 42(2):138-146. PubMed ID: 32756862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the role of bone biopsy in the management of patients with CKD-MBD.
    Evenepoel P; Behets GJS; Laurent MR; D'Haese PC
    J Nephrol; 2017 Oct; 30(5):645-652. PubMed ID: 28831679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.